Articles

Lululemon’s stock rallies toward a 10-month high after guidance for profit, revenue and gross margin were raised.

Macy’s gave its fourth-quarter update just days after announcing a slate of store closures.

When your neighborhood is destroyed by fire, what do you take with you? And how do you face the future?

Moderna’s stock tumbles after a disappointing outlook for revenue and the need to accelerate its cost-cutting plan.

The largest banks in the U.S. may justify further gains in stock prices if their earnings updates in the coming days include any upside surprises around loan growth or a boost from lighter regulations expected by the Trump administration.

The U.S. will lose the global AI race unless Washington drives tech innovation and neutralizes cyberattacks on financial institutions.

Investors should stick to quality names amid rising rates, says a team led by Morgan Stanley’s Mike Wilson.

Oil futures were up strongly Monday, with Brent crude on track for its first finish above $80 a barrel since August, as investors assess the potential hit to supply from a further tightening of sanctions on Russia’s oil sector.

Pharma giant Johnson & Johnson is buying Intra-Cellular Therapies, eying sales growth above analysts’ expectations through 2029.

A relief rally should be well underway by now. Investors should be patient.

The S&P 500 is probably halfway through its setback already, says Truist strategist.

The White House on Monday announced new restrictions on artificial intelligence exports that will impact companies including Nvidia.